[Gene therapy for the treatment of restenosis after coronary angioplasty].
Accumulation and proliferation of vascular smooth muscle cells are associated with atherosclerosis and hypertension. Proliferation of smooth muscle cells constitutes a major pathological event responsible for long-term failure of coronary and peripheral arterial bypass graft as well as the development of restenosis after percutaneous transluminal coronary angioplasty (PTCA). The incidence of restenosis after PTCA has been reported to be as high as 40-45% within 3-6 months. Major advantages in recombinant deoxyribonucleic acid (DNA) technology and eukaryotic gene regulation allow to hypothesize gene therapy as a potential treatment for inherited and acquired diseases. Gene therapy is the introduction of genes into somatic cells to correct an inherited or acquired disorder through the synthesis of missing or defective protein. Although no disease has yet been treated by gene therapy, several gene transfer protocols have recently been undertaken. We have studied the expression of foreign DNA that has been introduced into smooth muscle cells after balloon carotid injury in a rat model of angioplasty. The effects of different degree of balloon injury on neointima formation and c-fos expression was also assessed. Our data demonstrate that site-specific gene expression can be achieved by direct gene transfer in vivo and could be applied to the treatment of restenosis after PTCA.
Rapacciuolo
A
A
Cattedra di Cardiologia, Università degli Studi Federico II, Napoli.
Indolfi
C
C
Di Lorenzo
E
E
Esposito
G
G
Stabile
E
E
Stingone
A M
AM
Avvedimento
E V
EV
Condorelli
M
M
Chiariello
M
M
D015906:Angioplasty, Balloon, Coronary; D000818:Animals; D001794:Blood Pressure; D003327:Coronary Disease / Q000235:genetics / Q000473:pathology / Q000503:physiopathology / Q000628:therapy*; D003331:Coronary Vessels / Q000473:pathology; D005786:Gene Expression Regulation / Q000235:genetics; D015316:Genetic Therapy / Q000379:methods*; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000473:pathology; D016760:Proto-Oncogene Proteins c-fos / Q000235:genetics; D051381:Rats; D011921:Rats, Inbred WKY; D012008:Recurrence; D013997:Time Factors
D016760:Proto-Oncogene Proteins c-fos
Terapia genica per il trattamento della ristenosi dopo angioplastica coronarica.